Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Beitsch

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2007
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011Anthony Lucci, Linda Mackie McCall, Peter D Beitsch, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2012
Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial DataJ Ben Wilkinson, Peter D Beitsch, Chirag Shah, et al.
Annals of Surgical Oncology|May 13, 2008
Getting to better cancer care: results of a society of surgical oncology surveySandra L Wong, Laurence E McCahill, Stephen B Edge, et al.
Annals of Surgical Oncology|June 10, 2020
Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast CancerMichael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, et al.
Annals of Surgery|December 29, 2004
Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancerSeth P Harlow, David N Krag, Thomas B Julian, et al.
Plos One|November 22, 2018
BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancerMi Jeong Kwon, Sae Byul Lee, Jinil Han, et al.
Annals of Surgical Oncology|July 13, 2019
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast CancerMichael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, et al.
The Breast Journal|January 15, 2009
The surgeon's role in breast brachytherapyPeter D Beitsch, Charles W Hodge, Kambiz Dowlat, et al.
Annals of Surgery|September 30, 2005
Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancerKatherine E Posther, Linda M McCall, Peter W Blumencranz, et al.
Annals of Surgical Oncology|August 8, 2014
Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)Pat Whitworth, Lisette Stork-Sloots, Femke A de Snoo, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2007
Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011Anthony Lucci, Linda Mackie McCall, Peter D Beitsch, et al.
International Journal of Radiation Oncology, Biology, Physics|November 28, 2012
Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial DataJ Ben Wilkinson, Peter D Beitsch, Chirag Shah, et al.
Annals of Surgical Oncology|May 13, 2008
Getting to better cancer care: results of a society of surgical oncology surveySandra L Wong, Laurence E McCahill, Stephen B Edge, et al.
Annals of Surgical Oncology|June 10, 2020
Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast CancerMichael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, et al.
Annals of Surgery|December 29, 2004
Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancerSeth P Harlow, David N Krag, Thomas B Julian, et al.
Plos One|November 22, 2018
BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancerMi Jeong Kwon, Sae Byul Lee, Jinil Han, et al.
Annals of Surgical Oncology|July 13, 2019
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast CancerMichael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, et al.
The Breast Journal|January 15, 2009
The surgeon's role in breast brachytherapyPeter D Beitsch, Charles W Hodge, Kambiz Dowlat, et al.
Annals of Surgery|September 30, 2005
Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancerKatherine E Posther, Linda M McCall, Peter W Blumencranz, et al.
Annals of Surgical Oncology|August 8, 2014
Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)Pat Whitworth, Lisette Stork-Sloots, Femke A de Snoo, et al.
Pageof 6